National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

NM-3
An orally bioavailable antiangiogenic isocoumarin with potential antineoplastic activity. NM-3 inhibits vascular endothelial growth factor (VEGF), a pro-angiogenic growth factor, thereby inhibiting endothelial cell proliferation. This agent also induces apoptosis by a mechanism involving reactive oxygen species. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:nimustine, Nipent, nitric oxide-releasing acetylsalicylic acid derivative, nitroglycerin, Nizoral
Next:NMPRTase inhibitor APO866, nolatrexed dihydrochloride, Nolvadex, nordihydroguaiaretic acid, norethindrone acetate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov